Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Total Debt/Equity(x) 0.030.04---

What is the latest Total Debt/Equity ratio of GLAND PHARMA ?

The latest Total Debt/Equity ratio of GLAND PHARMA is 0.03 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.03
Mar20240.04
Mar2023-
Mar2022-
Mar2021-

How is Total Debt/Equity of GLAND PHARMA Trending?

Years Total Debt/Equity % Change
Mar2025 0.03
-25.00
Mar2024 0.04
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of GLAND PHARMA


Compare Total Debt/Equity ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹26,564.9 Cr -1.4% -12.2% 2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,767.6 Cr -4.6% -8% -16.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.4%

-12.2%

2.8%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses